COLLECTING DUCT RENAL CELL CARCINOMA
Clinical trials for COLLECTING DUCT RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new COLLECTING DUCT RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for COLLECTING DUCT RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for rare kidney cancers
Disease control OngoingThis study tests whether combining two drugs, nivolumab and cabozantinib, can shrink tumors in people with advanced or metastatic non-clear cell kidney cancer. About 60 participants who have had little or no prior treatment will receive the drug combination. The goal is to see ho…
Matched conditions: COLLECTING DUCT RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:07 UTC
-
New drug cocktail shows promise in slowing tough kidney cancers
Disease control OngoingThis study tests whether a combination of three drugs (cabozantinib, nivolumab, and ipilimumab) can safely slow the growth of advanced kidney cancer that has spread. About 60 adults with certain types of kidney cancer that cannot be removed by surgery will receive the treatment. …
Matched conditions: COLLECTING DUCT RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Bradley A. McGregor, MD • Aim: Disease control
Last updated May 22, 2026 14:05 UTC